Results
Thyrocare Q2 FY27 PAT Up 26% YoY, Divests NHL
Thyrocare reported 25.1% YoY consolidated revenue growth and 25.7% YoY PAT growth before exceptions in Q2 FY27.
The company divested its Nueclear Healthcare Ltd (NHL) subsidiary for INR 141.4 Cr, resu
